The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer’s
disease.
2021
Simrén J, Leuzy A, Karikari TK, Hye A, Benedet AL, Lantero-Rodriguez J, Mattsson-
Carlgren N, Schöll M, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H,
Lovestone S, Aarsland D; AddNeuroMed consortium, Hansson O, Rosa-Neto P,
Westman E, Blennow K, Zetterberg H, Ashton NJ.
Alzheimers Dement. 2021 Jan 25. Online ahead of print.